C7H16N2
Neat
128.22
1354469-76-3; (3R, 4R)-N, 4-dimethylpiperidin-3-amine; (3R, 4R)-N, 4-dimethyl-piperidin-3-amine; 1206875-43-5; Cis-N, 4-dimethylpiperidin-3-amine; MFCD18071685; Tosylsarcosine-13C3; N-Methyl-N-[(4-methylphenyl)sulfonyl]glycine-13C3; N-Tosylsarcosine-13C3; N-Methyl-N-[(4-methylphenyl)sulfonyl]-glycine-13C3; N-(p-Tolylsulfonyl)-sarcosine-13C3; PUW5RSU9Z5; 3-piperidinamine, n, 4-dimethyl-, (3r, 4r)-rel-; Tofacitinib Related Impurity 1; SCHEMBL1853773; cis-N, 4-Dimethyl-3-piperidinamine; N, 4-Dimethyl-3-piperidinamine, cis-; CS-0166087; rel-(3R, 4R)-N, 4-Dimethyl-3-piperidinamine; EN300-19656492; (3R, 4R)-N and 4-dimethylpiperidin-3-amine? (Tofacitinib Impurity
(3R, 4R)-N and 4-dimethylpiperidin-3-amine
InChI=1S/C7H16N2/c1-6-3-4-9-5-7(6)8-2/h6-9H,3-5H2,1-2H3/t6-,7+/m1/s1